Overview

Pharma Ophthalmic Market Overview:

FutureWise Market Research has illustrated a report on the Pharma Ophthalmic Market. The report provides an in-depth anatomy of market trends affecting its growth. Moreover, it includes intricate insights on profitability graph, the market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of Pharma Ophthalmic Market.

The Pharma Ophthalmic market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Pharma Ophthalmic Market are:    
• Novartis
• Allergan
• Roche
• Valeant
• Regeneron
• Santen
• Bayer
• Pfizer
• Senju
• Akorn
(Note: The list of the major players will be updated with the latest market scenario and trends)

Pharma Ophthalmic Market Segmentation:

By Product Type
• Retinal disorders drugs
• Allergic, inflammatory and infective drugs
• Glaucoma drugs
• Dry eye drugs
• Other ophthalmic drugs
By Application
• Glaucoma
• Dry eye syndrome
• Retinal diseases
• Other ophthalmic indications
By Region
• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East & Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the market by product, by product type, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key countries— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1 Objectives of the Study 
        1.2 Market Definition 
        1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
        1.4 Currency 
        1.5 Limitations 
        1.6 Stakeholders 
2. Research Methodology 
        2.1 Research Data 
             2.1.1 Secondary Data
                 2.1.1.1 Key Data From Secondary Sources
             2.1.2 Primary Data
                 2.1.2.1 Key Data From Primary Sources
        2.2 Market Size Estimation 
        2.3 Market Breakdown and Data Triangulation 
        2.4 Assumptions for the Study  
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Global Pharma Ophthalmic Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Market Overview
     5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Pharma Ophthalmic Market Analysis Tools
         6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Pharma Ophthalmic Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
           7.1. Retinal disorders drugs
           7.2. Allergic, inflammatory and infective drugs
           7.3. Glaucoma drugs
           7.4. Dry eye drugs
           7.5. Other ophthalmic drugs
8. Global Pharma Ophthalmic Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
           8.1. Glaucoma
           8.2. Dry eye syndrome
           8.3. Retinal diseases
           8.4. Other ophthalmic indications
9. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           9.1. Introduction
           9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                 9.2.1. U.S.A
                 9.2.2. Canada
                 9.2.3. Mexico
           9.3. Market Size (USD Million) Forecast for North America 2022-2028 
10. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           10.1. Introduction
           10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   10.2.1. Brazil
                   10.2.2. Venezuela
                   10.2.3. Argentina
                   10.2.4. Rest of Latin America
           10.3. Market Size (USD Million) Forecast for Latin America 2022-2028  
11. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           11.1. Introduction
           11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   11.2.1. Germany
                   11.2.2. U.K
                   11.2.3. France
                   11.2.4. Italy
                   11.2.5. Spain
                   11.2.6. Russia
                   11.2.7. Poland
                   11.2.8. Rest of Europe
           11.3. Market Size (USD Million) Forecast for Europe 2022-2028
12. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           12.1. Introduction
           12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   12.2.1. Japan
                   12.2.2. China
                   12.2.3. India
                   12.2.4. Australia and New Zealand
                   12.2.5. ASEAN
                   12.2.6. Rest of Asia Pacific
            12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2015–2020 and Forecast 2022–2028 (USD Million)
           13.1. Introduction
           13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2020
                   13.2.1. GCC
                   13.2.2. Israel
                   13.2.3. South Africa
                   13.2.4. Rest of MEA
           13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
         14.1. Novartis
                14.1.1. Company Overview
                14.1.2. Product Portfolio
                14.1.3. SWOT Analysis
                14.1.4. Financial Overview
                14.1.5. Strategic Overview
         14.2. Allergan
                14.2.1. Company Overview
                14.2.2. Product Portfolio
                14.2.3. SWOT Analysis
                14.2.4. Financial Overview
                14.2.5. Strategic Overview
         14.3. Roche
                14.3.1. Company Overview
                14.3.2. Product Portfolio
                14.3.3. SWOT Analysis
                14.3.4. Financial Overview
                14.3.5. Strategic Overview
         14.4. Valeant                
                14.4.1. Company Overview
                14.4.2. Product Portfolio
                14.4.3. SWOT Analysis
                14.4.4. Financial Overview
                14.4.5. Strategic Overview
         14.5. Regeneron
                14.5.1. Company Overview
                14.5.2. Product Portfolio
                14.5.3. SWOT Analysis
                14.5.4. Financial Overview
                14.5.5. Strategic Overview
         14.6. Santen
                14.6.1. Company Overview
                14.6.2. Product Portfolio
                14.6.3.  SWOT Analysis
                14.6.4. Financial Overview
                14.6.5. Strategic Overview
         14.7. Bayer
                14.7.1. Company Overview
                14.7.2. Product Portfolio
                14.7.3. SWOT Analysis
                14.7.4. Financial Overview
                14.7.5. Strategic Overview
         14.8. Pfizer
                14.8.1. Company Overview
                14.8.2. Product Portfolio
                14.8.3. SWOT Analysis
                14.8.4. Financial Overview
                14.8.5. Strategic Overview
         14.9. Senju
                14.9.1. Company Overview
                14.9.2. Product Portfolio
                14.9.3. SWOT Analysis
                14.9.4. Financial Overview
                14.9.5. Strategic Overview
         14.10. Akorn
                14.10.1. Company Overview
                14.10.2. Product Portfolio
                14.10.3.  SWOT Analysis
                14.10.4. Financial Overview
                14.10.5. Strategic Overview
15. Pre and Post COVID-19 Impact
    15.1. Positive influence on the healthcare industry
    15.2. The financial disruption of the manufacturing sector
    15.3. Impact of COVID-19 on emerging companies
    15.4. Significant mandates in the healthcare regulations initiated by administrations
    15.5. The overall economic slowdown of the developing and developed nations
16. FutureWise SME key takeaway points for Client

Tables

Figures